Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptolide Wilfordii in HIV-infected Immunological Non-responders
NCT01817283Phase 2Unknown
- Start
- Jan 2013
- Primary completion
- Jul 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triptolide in human immunodeficiency virus infection (HIV). Status: unknown.
02
Drugs
triptolide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01817283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01817283.